3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide

C29H36N4O4 — CID 118417701

IUPAC3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide
SMILESCc1cccc(C(=O)N[C@H](C(=O)N2CCC3(CC2)C(=O)N(C)CN3c2ccccc2)C2CCOCC2)c1
InChIInChI=1S/C29H36N4O4/c1-21-7-6-8-23(19-21)26(34)30-25(22-11-17-37-18-12-22)27(35)32-15-13-29(14-16-32)28(36)31(2)20-33(29)24-9-4-3-5-10-24/h3-10,19,22,25H,11-18,20H2,1-2H3,(H,30,34)/t25-/m0/s1
InChIKeyLEQNBKIUGXBMTP-VWLOTQADSA-N
MW504.63 g/mol
LogP2.82
Rot. Bonds5

About 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide

3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide (PubChem CID 118417701) has the molecular formula C29H36N4O4 and a molecular weight of 504.63 g/mol. Its IUPAC name is 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide.

Molecular Properties

Compound Name3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide
PubChem CID118417701
Molecular FormulaC29H36N4O4
Molecular Weight504.63 g/mol
Exact Mass504.27
IUPAC Name3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide
SMILESCc1cccc(C(=O)N[C@H](C(=O)N2CCC3(CC2)C(=O)N(C)CN3c2ccccc2)C2CCOCC2)c1
InChIInChI=1S/C29H36N4O4/c1-21-7-6-8-23(19-21)26(34)30-25(22-11-17-37-18-12-22)27(35)32-15-13-29(14-16-32)28(36)31(2)20-33(29)24-9-4-3-5-10-24/h3-10,19,22,25H,11-18,20H2,1-2H3,(H,30,34)/t25-/m0/s1
InChIKeyLEQNBKIUGXBMTP-VWLOTQADSA-N
XLogP2.82
TPSA82.19 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500504.63
LogP ≤ 52.82
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide?
The IUPAC name of 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide (CID 118417701) is 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide.
What is the SMILES notation for 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide?
The canonical SMILES for 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide is Cc1cccc(C(=O)N[C@H](C(=O)N2CCC3(CC2)C(=O)N(C)CN3c2ccccc2)C2CCOCC2)c1.
What is the InChIKey of 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide?
The InChIKey is LEQNBKIUGXBMTP-VWLOTQADSA-N. The full InChI is InChI=1S/C29H36N4O4/c1-21-7-6-8-23(19-21)26(34)30-25(22-11-17-37-18-12-22)27(35)32-15-13-29(14-16-32)28(36)31(2)20-33(29)24-9-4-3-5-10-24/h3-10,19,22,25H,11-18,20H2,1-2H3,(H,30,34)/t25-/m0/s1.
What are the key properties of 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide?
3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide has a molecular weight of 504.63 g/mol, XLogP of 2.82, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methyl-N-[(1S)-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-(oxan-4-yl)-2-oxoethyl]benzamide is sourced from PubChem (CID 118417701), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).